Kappa Opioid receptor

Results: 54



#Item
1INRC 2010 Program Sunday July 11, 00 RegistrationReception  Monday July 12, 2010

INRC 2010 Program Sunday July 11, 00 RegistrationReception Monday July 12, 2010

Add to Reading List

Source URL: www.inrcworld.org

Language: English - Date: 2010-07-07 14:19:33
2Microsoft Word - PremioJRV2010.doc

Microsoft Word - PremioJRV2010.doc

Add to Reading List

Source URL: www.sbfte.org.br

Language: English - Date: 2015-04-07 16:01:07
3Checklist For Opioid Prescribing In Chronic Non-Cancer Pain A) COMPREHENSIVE ASSESSMENT “Bio-”:  Underlying treatable condition (if possible)

Checklist For Opioid Prescribing In Chronic Non-Cancer Pain A) COMPREHENSIVE ASSESSMENT “Bio-”: Underlying treatable condition (if possible)

Add to Reading List

Source URL: www.anzca.edu.au

Language: English - Date: 2015-01-26 19:53:11
4A new target for alcoholism treatment: Kappa opioid receptors

A new target for alcoholism treatment: Kappa opioid receptors

Add to Reading List

Source URL: medicalxpress.com

Language: English - Date: 2015-04-13 00:39:44
5CDC—Drug Overdose Prevention.

CDC—Drug Overdose Prevention.

Add to Reading List

Source URL: www.cdc.gov

Language: English - Date: 2015-02-19 11:26:56
6UTAH DEPARTMENT OF HEALTH, PRIOR AUTHORIZATION BUTRANS (buprenorphine) Patient name:___________________________________Medicaid ID #:________________________________ Prescriber Name:_________________Prescriber NPI#:_____

UTAH DEPARTMENT OF HEALTH, PRIOR AUTHORIZATION BUTRANS (buprenorphine) Patient name:___________________________________Medicaid ID #:________________________________ Prescriber Name:_________________Prescriber NPI#:_____

Add to Reading List

Source URL: medicaid.utah.gov

Language: English - Date: 2014-08-07 16:26:15
7Kappa Opioid Receptor Agonists and Antagonist Summary: The present invention is an entirely new chemotype of KOR weak partial agonists. Contact Information: Matt Koenig, J.D. KU Innovation & Collaboration[removed]m

Kappa Opioid Receptor Agonists and Antagonist Summary: The present invention is an entirely new chemotype of KOR weak partial agonists. Contact Information: Matt Koenig, J.D. KU Innovation & Collaboration[removed]m

Add to Reading List

Source URL: kuic.ku.edu

Language: English - Date: 2014-01-30 10:26:50
8Novel Methods for Antagonizing Kappa Opioid Receptors Summary: The invention is a method for antagonizing kappa opioid receptors (KOR) present in tissue in vitro or in vivo. Contact Information: Aswini K. Betha, Ph.D. KU

Novel Methods for Antagonizing Kappa Opioid Receptors Summary: The invention is a method for antagonizing kappa opioid receptors (KOR) present in tissue in vitro or in vivo. Contact Information: Aswini K. Betha, Ph.D. KU

Add to Reading List

Source URL: kuic.ku.edu

Language: English - Date: 2014-01-30 10:23:55
9Salvia divinorum Profile Salvia divinorum, also known as S. divinorum or Salvia, is a hallucinogenic plant native to the northeastern Sierra Mazateca mountain region of Mexico, where the native Mazatecs have used it for

Salvia divinorum Profile Salvia divinorum, also known as S. divinorum or Salvia, is a hallucinogenic plant native to the northeastern Sierra Mazateca mountain region of Mexico, where the native Mazatecs have used it for

Add to Reading List

Source URL: www.cesar.umd.edu

Language: English - Date: 2013-10-29 10:10:47
10Saskatchewan Drug Information Services College of Pharmacy and Nutrition, U of S T:([removed]F:([removed]www.druginfo.usask.ca  Volume 28, Issue No. 1

Saskatchewan Drug Information Services College of Pharmacy and Nutrition, U of S T:([removed]F:([removed]www.druginfo.usask.ca Volume 28, Issue No. 1

Add to Reading List

Source URL: medsask.usask.ca

Language: English - Date: 2013-03-14 12:11:17